These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6798791)

  • 1. [Various features of dopamine metabolism in schizophrenia].
    Anokhina IP; Kogan BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1343-7. PubMed ID: 6798791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia].
    Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):700-8. PubMed ID: 6168149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
    Krupenina LB; Vinogradov MV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):737-45. PubMed ID: 6106335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differences in serotonin and dopamine metabolism in psychopathy and sluggish schizophrenia].
    Zabrodin GD; Turova ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(11):1673-7. PubMed ID: 1015096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis and treatment of torsion dystonia].
    Barkhatova VP; Markova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1121-8. PubMed ID: 696099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of catecholamines in the biochemical mechanisms of the pathogenesis of hepatocerebral dystrophy].
    Barkhatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):78-84. PubMed ID: 7124230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excretion of catecholamines and tryptophan derivatives in schizophrenia].
    Mileikovskii IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):710-4. PubMed ID: 132832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine].
    Valori C; Brunori CA; Renzini V; Porcellati C
    Ann Ist Super Sanita; 1971; 7(2):414-21. PubMed ID: 5155304
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N; Nagasaka N
    ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of free and conjugated catecholamines, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid in the urine and blood plasma by high pressure liquid chromatography].
    Kogan BM; Drozdov AZ; Man'kovskaia IV; Filatova TS
    Klin Lab Diagn; 1995; (3):25-8. PubMed ID: 8689050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comprehensive method of determining catecholamines, DOPA and 5-hydroxyindoleacetic acid in urine].
    Nikiragina GP; Khoreva SA
    Lab Delo; 1988; (9):8-11. PubMed ID: 2461495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Features of the functioning of the catecholamine and adrenocortical systems of patients with depression and different degrees of emotional tension].
    Anokhina ID; Bol'shakova TD; Bremer GP; Buniatian AF; Ignatenko LL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1703-8. PubMed ID: 3101334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the determination of adrenaline, noradrenaline, dopamine and dopa in a single urine sample].
    Matlina ESh; Kiseleva ZM
    Probl Endokrinol Gormonoter; 1966; 12(2):111-6. PubMed ID: 6004103
    [No Abstract]   [Full Text] [Related]  

  • 16. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
    Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
    J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
    Oades RD; Klimke A; Henning U; Rao ML
    Hum Psychopharmacol; 2002 Jan; 17(1):15-27. PubMed ID: 12404703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
    Magalov ShI; Dadali EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1158-63. PubMed ID: 6452012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biogenic amine metabolism in patients with oligophrenia of different origins].
    Bulakhova LA; Usherenko LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1563-7. PubMed ID: 6229120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF; Grosset K; Grosset D
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.